Literature DB >> 12646633

The possible role of TGF-beta-induced suppressors of cytokine signaling expression in osteoclast/macrophage lineage commitment in vitro.

Simon W Fox1, S Jaharul Haque, Alison C Lovibond, Timothy J Chambers.   

Abstract

Osteoclast formation is dependent on the ability of TGF-beta to enable receptor activator of NF-kappaB ligand (RANKL)-induced commitment of hemopoietic precursors to the osteoclastic lineage. The mechanism by which TGF-beta enables formation is unknown. One possibility is that TGF-beta opposes Janus kinase (JAK)/STAT signals generated by inhibitory cytokines such as IFN-beta. The JAK/STAT pathway is activated by cytokines that induce resistance to osteoclast formation, such as IFN-gamma and M-CSF, and the effect of these is opposed by TGF-beta. Recently, a group of STAT-induced factors, termed suppressors of cytokine signaling (SOCS), has been identified that inhibit JAK/STAT signals. Therefore, we tested the ability of TGF-beta to induce SOCS expression in osteoclast precursors and examined the effect of SOCS expression on osteoclast/macrophage lineage commitment. We found that while SOCS mRNA is undetectable in macrophages, osteoclasts express SOCS-3, and TGF-beta up-regulates this expression. Furthermore, TGF-beta rapidly induces sustained SOCS-3 expression in macrophage/osteoclast precursors. To determine whether SOCS-3 plays a role in osteoclast differentiation we expressed SOCS-3 in precursors using a retroviral system. We found that osteoclast differentiation was significantly enhanced in SOCS-3-infected precursors, and SOCS-3 expression enables formation in the presence of anti-TGF-beta Ab. On the other hand, antisense knockdown of SOCS-3 strongly suppressed osteoclast formation and significantly blunted the response to TGF-beta. Moreover, like TGF-beta, SOCS-3 expression opposed the inhibitory effect of IFN-beta. These data suggest that TGF-beta-induced expression of SOCS-3 may represent a mechanism by which TGF-beta suppresses inhibitory cytokine signaling, priming precursors for a role in bone resorption.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646633     DOI: 10.4049/jimmunol.170.7.3679

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Postmenopausal osteoporosis, T cells, and immune dysfunction.

Authors:  Steven L Teitelbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-22       Impact factor: 11.205

2.  Cerebral preconditioning using cortical application of hypertonic salt solutions: upregulation of mRNAs encoding inhibitors of inflammation.

Authors:  Hiromi Muramatsu; Frank A Welsh; Katalin Karikó
Journal:  Brain Res       Date:  2006-05-24       Impact factor: 3.252

Review 3.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

4.  Interferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression.

Authors:  Luiz F Leomil Coelho; Gabriel Magno de Freitas Almeida; Franck J D Mennechet; Anne Blangy; Gilles Uzé
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-04       Impact factor: 11.205

5.  Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system in patients with beta-thalassemia major.

Authors:  Nicholas G Angelopoulos; Anastasia Goula; Eugenia Katounda; Grigorios Rombopoulos; Victoria Kaltzidou; Dimitrios Kaltsas; Sophia Malaktari; Vassilis Athanasiou; George Tolis
Journal:  J Bone Miner Metab       Date:  2007-01-01       Impact factor: 2.626

6.  SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis.

Authors:  Peter K K Wong; Paul J Egan; Ben A Croker; Kristy O'Donnell; Natalie A Sims; Sarah Drake; Hiu Kiu; Edward J McManus; Warren S Alexander; Andrew W Roberts; Ian P Wicks
Journal:  J Clin Invest       Date:  2006-05-18       Impact factor: 14.808

7.  Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation.

Authors:  Mary Karst; Genevieve Gorny; Rachelle J Sells Galvin; Merry Jo Oursler
Journal:  J Cell Physiol       Date:  2004-07       Impact factor: 6.384

Review 8.  Osteoimmunology: cytokines and the skeletal system.

Authors:  Seoung-Hoon Lee; Tae-Soo Kim; Yongwon Choi; Joseph Lorenzo
Journal:  BMB Rep       Date:  2008-07-31       Impact factor: 4.778

Review 9.  Osteoclasts-Key Players in Skeletal Health and Disease.

Authors:  Deborah Veis Novack; Gabriel Mbalaviele
Journal:  Microbiol Spectr       Date:  2016-06

10.  Involvement of SOCS3 in regulation of CD11c+ dendritic cell-derived osteoclastogenesis and severe alveolar bone loss.

Authors:  Xiaoxia Zhang; Mawadda Alnaeeli; Bhagirath Singh; Yen-Tung A Teng
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.